O2-11-5Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer who have poor performance status
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI